Stay updated on Vibecotamab in MRD+ AML/MDS Clinical Trial
Sign up to get notified when there's something new on the Vibecotamab in MRD+ AML/MDS Clinical Trial page.

Latest updates to the Vibecotamab in MRD+ AML/MDS Clinical Trial page
- Check7 days agoChange DetectedAdded a page revision note 'Revision: v3.3.3' to the history list and removed the 'HHS Vulnerability Disclosure' and the previous 'Revision: v3.3.2' entry from the footer. These are administrative updates that do not affect study data or user actions.SummaryDifference0.2%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check35 days agoChange DetectedRevision: v3.3.2 was added and Revision: v3.2.0 was removed from the page history, reflecting a routine software update.SummaryDifference0.1%

- Check43 days agoChange DetectedThe site-wide funding-status notice about government funding and operating status was removed. The page content and study history details remain unchanged.SummaryDifference0.6%

- Check57 days agoChange DetectedThe new screenshot shows minor layout adjustments on the Record History page, with no changes to study data, statuses, or version history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check64 days agoChange DetectedNew 2025-10-27 update adds the Study Status entry to the record history; the total versions now show 16, and an older entry from 2025-06-03 was removed.SummaryDifference0.4%

- Check86 days agoChange DetectedNew operating-status notice and version update to v3.2.0; previous v3.1.0 version tag removed.SummaryDifference12%

Stay in the know with updates to Vibecotamab in MRD+ AML/MDS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Vibecotamab in MRD+ AML/MDS Clinical Trial page.